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bstract
Lipid rafts is a blanket term used to describe distinct areas in the plasma membrane rich in certain lipids and proteins and which are thought to
erform diverse functions. A large number of studies report on lipid rafts having a key role in receptor signalling and activation of lymphocytes.
n T cells, lipid raft involvement was demonstrated in the early steps during T cell receptor (TCR) stimulation. Interestingly, recent evidence has
hown that signalling in these domains differs in T cells isolated from patients with autoimmune diseases such as systemic lupus erythematosus
SLE) and rheumatoid arthritis (RA). Here, we discuss these findings and explore the potential of lipid rafts as targets for the development of a
ew class of agents to downmodulate immune responses and for the treatment of autoimmune diseases.
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. Signalling by the T cell receptor (TCR)
The TCR recognizes peptides presented in the context of
ppropriate major histocompatibility complex (MHC) proteins
xpressed on the surface of antigen presenting cells (APCs).
The immediate outcome of TCR stimulation is tyrosine phos-
phorylation of immunoreceptor tyrosine-based activation motifs
(ITAMs) present in the cytoplasmic domains of the chains (, ,
, and ) that comprise the TCR-associated CD3 complex [2,3].
ITAM phosphorylation is mediated by the Src-family tyrosineignalling cascades that branch out of the stimulated TCR in
onjunction with signals that originate from concomitantly stim-
lated co-receptors result in the activation of the T cell and
evelopment of effector functions [1].
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Open access under CC BY license.inase Lck [4,5]. The phosphorylated TCR recruits to the plasma
embrane the cytosolic ZAP-70 tyrosine kinase [6], the main
ubstrate of which is the transmembrane adaptor LAT (linker for
ctivation of T cells). In turn, LAT phosphorylation triggers the
ormation of multi-protein signalling complexes at the plasma
embrane. Proteins that participate in such assemblies include
ther scaffold molecules such as Grb-2, SLP-76, and Gads, and
nzymes like phospholipase C (PLC) 1 and phosphoinositide
-kinase (PI3K) [7–9]. The LAT-nucleated complexes at the
ytoplasmic face of the plasma membrane control downstream
ignalling pathways that lead to changes in cell morphology and
ene transcription.
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Recognition of antigen/MHC complexes by the TCR is
ssisted by co-receptors, CD4 and CD8, and co-stimulatory
eceptors such as CD28, expressed on the surface of T cells
hat pair with their cognate ligands on the APC. The coordinated
ction of these interactions and ensuing signalling result in a sta-
le, yet dynamic, zone of contact between the two cells which
as been named the immunological synapse (IS) (reviewed in
ef. [10]). The plasticity of the IS became apparent through
maging studies showing temporal and spatial recruitment of var-
ous co-receptors and signalling molecules within subdomains
f the synapse [11]. For example, in the mature IS, the central
egion of the synapse, where the T cell and APC membranes are
n close proximity, concentrates the TCR, the CD4 and CD28
eceptors, and associated signalling molecules such as Lck and
rotein kinase C (PKC)  [12]. Larger and heavily glycosylated
olecules such as CD44, CD45 and CD43 are excluded from the
entral region and preferentially occupy a peripheral area that
urrounds the core of the synapse [13,14]. Lipid rafts are found
o accumulate at the IS, as was reported by staining the cells
ith cholera toxin B subunit (CTB), which binds to Ganglioside
1 (GM1), a marker of raft membranes [15,16]. Furthermore,
sing the fluorescent probe Laurdan, condensation of the plasma
embrane was detected at the site of the IS, suggesting accumu-
ation of lipid rafts [17]. Interestingly, the tyrosine phosphatase
D45 has been shown to transiently move to the proximity of
he TCR at the later stages during T cell/APC interaction [18].
owever, initial TCR activation and early tyrosine phosphoryla-
ion precedes formation of the IS and occurs in TCR-containing
icroclusters which form within seconds of the initial TCR-
HC/antigen contact and contain activated Lck, ZAP-70, and
AT [19,20]. Subsequent formation of the IS not only provides
he sustained signal needed for gene transcription but may also
ontrol the eventual cessation of the signal and downregulation
f the immune response.
. Lipid rafts in T cells; size matters
The term lipid raft is used to describe microdomains in
he plasma membrane that are in liquid-ordered phase owing
o their lipid composition which is rich in cholesterol, gly-
osphingolipids, and sphingomyelin [21–23]. As a result, their
tructural properties are different from the glycerophospholipid-
ich bilayer which comprises the bulk of the plasma membrane
24]. Although it is agreed that in unstimulated cell lipid rafts
re too small to resolve with the light microscope, their actual
ize and protein composition is an area of ongoing debate
25,26]. While some groups report a size between 50 and
00 nm [27], others have measured a much smaller size of
20 nm [28]. This is a key issue that needs to be addressed
f we are to better understand their function (the reader is also
eferred to the accompanying reviews in this issue). For example,
icrodomains of a larger size will promote compartmentaliza-
ion of plasma membrane proteins that have higher affinity for
he liquid-ordered phase, while they will exclude proteins that
ave higher affinity for the liquid-disordered phase. In this sce-
ario, some protein–protein interactions will be favoured while
thers will be prevented. This arrangement may change upon
t
T
apmental Biology 18 (2007) 608–615 609
hysiological stimulation of receptors such as the TCR. This
odel has been the ‘classical’ raft hypothesis. On the other
and, if lipid rafts are of smaller size (<20 nm) they will be
ble to accommodate only few protein molecules. Although it is
ifficult to see how such ‘nanodomains’ could induce any sig-
ificant segmentation of the membrane, a recent computational
odeling study on raft–protein dynamics indicated that small,
obile rafts can reduce the diffusion rate of associated proteins
nd hence increase protein–protein collisions. In contrast, pro-
eins that are excluded from rafts did not show reduced mobility
29]. Furthermore, coalesence of these small, highly mobile,
nd probably short-lived, units into larger structures under cer-
ain conditions, such as receptor triggering, will enable them
o adopt the properties of larger rafts as mentioned above [30].
arger rafts are likely to be controlled by endocytosis unless
tabilized by, for example, receptor stimulation [31]. Receptor-
nduced protein–protein interactions also have a critical role and
ill further facilitate aggregation and signalling [32]. In this
odel, any change in the status of the lymphocyte that results
n higher accumulation of lipids which are constituents of raft
embrane, is likely to profoundly change membrane organi-
ation by supporting formation of larger rafts. These changes
ay in turn influence the strength or duration of receptor sig-
al. Thus, inappropriate changes in the size and/or structure of
ipid rafts could influence their stability and may result in abnor-
al signalling and pathological conditions. Changes in the level
f membrane cholesterol and GM1 have been reported in acti-
ated and autoimmune lymphocytes (see Fig. 1 and Section 4
elow).
. Lipid rafts in TCR signalling
Historically, the interest of immunologists in T cell lipid rafts
riginated from the observation that Lck, which phosphorylates
he TCR ITAMs, localizes to these domains owing to its N-
erminal dual acylation [33–35]. It was shown that the ability
f the kinase to support TCR signalling critically depends on
ts lipid modification [35,36]. Soon after, LAT was found to
artition to raft domains through palmitoylation of two cysteine
esidues that are in juxtaposition to its transmembrane segment
7]. As with Lck, mutation of the cysteines delocalizes LAT and
egates its biological function [37].
Like all the Src-family kinases, Lck activity is regulated
y the phosphorylation-dephosphorylation cycle of two tyro-
ine (Y) residues located in the catalytic domain (Y394) and
he C-terminus (Y505) of the protein [38]. Phosphorylation of
505 by Csk (C-terminal Src kinase) [39] induces its inter-
ction with the Src homology (SH) 2 domain of the protein
ausing the folding of the molecule into a ‘closed’ conformation
hich has low enzymatic activity [40,41]. In contrast, autophos-
horylation of Y394 forces the unfolding of the protein into
n ‘open’ configuration which has substantially higher activity
42].The activity of Lck is also regulated by CD45, a receptor-type
yrosine phosphatase which dephosphorylates Y505 [40,43].
he constitutive action of CD45 maintains a pool of Lck in
primed form ready to support signalling by the TCR. The
610 E.C. Jury et al. / Seminars in Cell & Developmental Biology 18 (2007) 608–615
Fig. 1. Increased levels of cholesterol and GM1 in the plasma membrane of T cells from patients with SLE and activated normal T cells. (A) Purified T cells from SLE
patients and healthy controls were labelled with the cholesterol chelator filipin and analysed by flow cytometry. The results shown are the cumulative data collected
from five lupus patients and five healthy volunteers. (B) SLE and normal T cells were stained with Alexa-fluor 594-conjugated cholera toxin B subunit (CTB-Alexa
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b94) and analysed by confocal microscopy. The images shown are adjusted to th
onors and two SLE patients. Bar = 10m. (C) Peripheral blood T cells from
ntibodies and stained with CTB-Alexa 594 or filipin to assess the levels of GM
mportance of CD45 has been highlighted by the absence of
CR signalling in mice and cell lines that are deficient in its
xpression [44,45]. It is important, however, to note that CD45
lso has a negative role in signalling by dephosphorylating Lck
t Y394 [46] and the CD3 chain [47]. Initially it was suggested
hat CD45 is excluded from raft domains [48]; however, subse-
uent reports have identified a small but detectable fraction of
he phosphatase in these domains [49,50]. How the cell balances
he positive and negative actions of CD45 during the early steps
f TCR signalling is not yet clear. A current theory that explains
ts dual role suggests that, while the phosphatase constitutively
aintains a pool of Lck primed for action, it is excluded from the
rea of TCR engagement upon stimulation of the receptor, due
o its large, heavily glycosylated extracellular domain, which
annot be accommodated into the narrow space created by the
lose proximity of the T cell and APC surfaces [13,51]. Accu-
ulation of lipid rafts and of Lck in these areas will shift the
alance towards increased phosphorylation and signal transduc-
ion [17,52]. This theory is supported by experiments showing
hat CD45 chimeras in which the extracellular portion has been
ubstituted by domains of progressively smaller size, gradually
ose their ability to support TCR signalling [50]. Furthermore,
t is known for many years that the various isoforms of CD45
hich differ in their extracellular domain also differ in their
bility to support TCR signalling [43].
A finding which at first glance seems to contradict this the-
ry is the observation that the pool of Lck present in lipid rafts
s phosphorylated on Y505 and is primarily in its ‘closed’ con-
ormation [48,53–55]. This could be due to the presence of the
AG-Csk inhibitory complex in lipid rafts. PAG (protein asso-
iated with GEMs or otherwise known as Csk binding protein
S
o
a
Te output intensity and are representative of samples generated from two healthy
hy donors were activated in vitro with a combination of anti-CD3/anti-CD28
cholesterol, respectively.
Cbp)) is a transmembrane adaptor which, like LAT, is palmi-
oylated on two membrane-proximal cysteines [56,57]. This
daptor is phosphorylated by Src-family kinases and recruits
sk to lipid rafts [55,58,59]. Recruited Csk in turn phosphory-
ates Lck at Y505 inducing its ‘closed’ conformation [55,59].
ecently, however, the generation of PAG-deficient animals has
evealed that recruitment of Csk to the membrane fraction and
ck Y505 phosphorylation is not significantly reduced in T cells,
uggesting that an additional, yet unidentified, Csk anchor exists
60]. Under certain conditions, such as receptor stimulation, a
yrosine phosphatase, possibly CD45, may transiently associate
ith lipid rafts dephosphorylating Y505 and converting raft-
ssociated Lck molecules into the ‘open’ structure (Fig. 2, top
anel) [61]. Interestingly, chimeras of CD45 which show better
ocalization to lipid rafts are able to support TCR signalling more
fficiently [50]. Lipid rafts containing primed Lck subsequently
ssociate with the microclusters of engaged TCRs, phospho-
ylating ITAMs and initiating signal transmission [62]. In this
cenario formation of TCR microclusters should precede phos-
horylation of the ITAMs by Lck. In support of this model Campi
t al. found that, in cells treated with inhibitors of Src kinases,
icroclusters of engaged TCRs were able to form, although tyro-
ine phosphorylation was abolished [19]. Rather, microcluster
ormation was dependent on actin polymerization [19]. Signifi-
antly, lipid raft microdomains were found to contain actin and
ther cytoskeletal proteins suggesting that their movement may
e regulated by reorganization of the actin cytoskeleton [63–66].
ubsequent formation of the IS will promote a wider segregation
f receptors and signalling proteins excluding CD45 from the
rea of TCR phosphorylation allowing for sustained signalling.
herefore, compartmentalization of CD45 both inside and out-
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Fig. 2. Differential association of signalling molecules to lipid raft domains in SLE may contribute to a breakdown in peripheral T cell tolerance. Higher synthesis of
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eholesterol and of other lipids could result in larger or more stable lipid raft dom
o-localization of CD45 phosphatase with lipid rafts and the higher Lck activity
ctivity could lower the threshold for TCR activation.
ide of lipid rafts could be a key issue in determining not only
he threshold but also the duration of TCR activation during an
mmune response.
. Lipid raft signalling in autoimmune T cells
The homeostasis of the immune system is stringently con-
rolled by the specificity and fidelity of lymphocyte activation.
n autoimmune diseases this specificity and fidelity is compro-
ised leading to pathology. Whether changes in the composition
r structure of lipid rafts play a role in autoimmunity is an impor-
ant question which has started to be addressed in the last few
ears. It was noted that human T cells activated in vitro via their
CR synthesize more GM1 lipid, a component of raft domains,
s detected by staining with CTB [67,68] and Fig. 1C). The
hysiological significance of this observation is not yet clear;
owever, it is possible that higher GM1 and cholesterol con-
ent report on an increased portion of the plasma membrane
eing in the liquid-ordered phase. As a result the lateral mobil-
ty of receptors and other signalling molecules may be reduced,
ncreasing compartmentalization of proteins at the plasma mem-
rane. Such changes may impact on thresholds for activation of
eceptors and possibly of the TCR. Indeed, over-loading healthy
cells with cholesterol reduces membrane fluidity and dis-
upts the interaction of signalling molecules [69]. Interestingly,
lasma membrane cholesterol has been linked to increased T cell
mmunosenescence associated with aging [70]. It is not known
hether the mobility of molecules associated with glycosph-
s

L
i. These changes in the plasma membrane could be the reason for the increased
n SLE T cells. Enhanced protein–protein interactions and changes in enzymatic
ngolipids such as glycosylphosphatidylinositol (GPI)-linked
eceptors, is altered in resting and activated cells.
Similarly, the plasma membrane of peripheral blood T cells
reshly purified from patients suffering from the autoimmune
isease SLE was found to contain more cholesterol and GM1,
onfirming that these cells have an activated phenotype ([71,72]
nd Fig. 1). When purified SLE T cells were cultured in vitro the
evels of cholesterol and GM1 gradually decreased to that seen
n naı¨ve T cells from healthy volunteers, indicating that stimuli
n the body of lupus patients activate T cells to increase synthe-
is of these lipids. Higher synthesis of the lipids was reinstated
ollowing TCR stimulation. Culturing the cells in the presence
f serum from SLE patients did not maintain the high expression
f GM1 and cholesterol, suggesting that cell to cell contacts are
eeded for the activation of SLE T cells in the body [71]. Rele-
ant is the finding that dendritic cells (DCs) from patients have
n activated phenotype due to the sustained action of interferon
lpha (INF) [73]. Activated DCs may be instrumental in the
resentation of autoantigens contributing to the activation of T
ells.
There are documented defects in the expression and func-
ion of various signalling molecules and pathways proximal
o the TCR in SLE T cells [74,75]. Among these are reduced
xpression of the canonical  chain of the TCR but expres-
ion of non-conventional  transcripts [76], expression of the
chain of the Fc receptor [77] and reduced expression of
ck [78]. Reduction in Lck expression was more pronounced
n T cells from patients with active disease and was indepen-
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ent of the treatment regime. Reduction of Lck expression is
robably due to a combination of reduced gene transcription
nd increased ubiquitination/degradation of the protein [78,79].
n accordance, SLE T cells when stimulated via the TCR are
oor activators of MAPK (mitogen-activated protein kinase)
athways and hypoproliferate in vitro [80,81]. Increased con-
umption of Lck via ubiquitination and degradation may be, at
east in part, due to the sustained stimulation of lupus T cells
y autoantigens, since it has been shown that sustained TCR
timulation leads to reduction in the expression of Lck [15].
Compared to healthy controls, lipid rafts from SLE T
ells were found to contain higher amounts of CD45 and co-
mmunoprecipitation experiments revealed that a larger fraction
f this pool was associated with Lck. As a consequence more
ck in lipid rafts was in the active form [71]. Therefore, an
ncrease in the localization of CD45 into lipid rafts is a key step
or Lck conversion to the active form and may be a critical step
n the activation of T cells. A similar observation was made with
lymphocytes isolated from SLE patients. Here again, higher
xpression of GM1 was noted as assessed by CTB binding, and
his was accompanied by reduced expression of Lyn, an Src-
amily kinase responsible for the phosphorylation of the ITAMs
n the B cell receptor (BCR) chains [82]. As in T cells, there was
n increase in the level of CD45 present in lipid rafts in SLE B
ells. Upon activation, CD45 recruitment to the site of activated
CRs was more prolonged in SLE B cells compared to cells
rom healthy volunteers, as was recruitment of Lyn [83]. Like
n T cells, these observations may indicate that B cells in SLE
atients are responding to a chronic stimulation by autoantigens.
One way of addressing the importance of higher cholesterol
ynthesis in TCR signalling is to treat cells with statins. These are
mall molecule inhibitors of 3-hydroxy-3-methylglutaryl coen-
yme A (HMG-CoA) reductase, the rate-limiting enzyme in
he biosynthetic pathway of cholesterol. Treatment of SLE T
ells with artorvastatin inhibited the co-localization of CD45
nd Lck in lipid rafts resulting in the reduction of active Lck
84]. This correlated with restoration of Lck expression back
o normal levels and ERK activation following TCR trigger-
ng [84]. Collectively these observations suggest that increased
ynthesis of cholesterol is associated with protein–protein inter-
ctions and signalling events that determine the activation status
f the lymphocyte. Therefore, pharmacological modification
f the structure and/or composition of lipid raft domains may
epresent a new method to downregulate immune responses in
athological conditions. Statins are already under investigation
s potential immuno-modulatory drugs in a range of inflamma-
ory and autoimmune diseases.
A second chronic inflammatory autoimmune disease where T
ells may play a role in the pathogenesis is rheumatoid arthritis
RA). In this case, T cells that are purified from the synovial fluid
SF) of inflamed joints, in contrast to T cells from the periph-
ry, were shown to have an activated phenotype, yet they were
yporesponsive to TCR stimuli and proliferated poorly [85,86].
his hyporesponsiveness may be the result of chronic oxida-
ive stress characteristic of the microenvironment of inflamed
oints. In T cells, oxidative stress was shown to result in the
isplacement of LAT from the membrane [87]. This was due to
c
c
a
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reduction in the levels of the anti-oxidant glutathione (GSH).
ddition of N-acetyl-l-cysteine restored LAT localization to the
embrane and TCR signalling [87,88]. Furthermore, reactive
xygen species (ROS)-mediated modification of Lck structure
as been reported in SF, but not peripheral blood T cells, from
A patients [89]. Therefore, under certain conditions ROS-
ediated modification of cysteine residues, which are targets of
-acylation, could delocalize proteins from lipid rafts and result
n inhibition of activation. This is highlighted by reports show-
ng that mutant mice with reduced capacity to produce ROS due
o a polymorphism in the neutrophil cytosolic factor 1 (Ncf1) are
ore prone to severe arthritis [90]. Furthermore, in T cells, ROS
roduction regulates surface redox levels to suppress autoreac-
ivity and development of arthritis [91]. A similar situation has
een observed with tumour infiltrating T cells (TILs) which, like
F T cells, are in a high oxidative stress microenvironment and
re defective in their ability to fully mobilize signalling pathways
ollowing TCR stimulation.
Taken together, these observations underline the importance
f lipid raft localization of proteins such as Lck, LAT and CD45,
s central to TCR signalling. Increased synthesis of cholesterol
nd of other lipids may alter the structure of the plasma mem-
rane of lymphocytes in a way that favours protein interactions
nd signalling. On the other hand, under certain conditions modi-
cation of critical residues in raft-associated proteins will disrupt
heir localization and inhibit cell activation. In both cases these
hanges profoundly impact on the function of lymphocytes by
ither supporting autoimmunity or failing to mount a response,
espectively.
. Conclusions and perspectives
A supposition of the lipid raft theory is that cholesterol and
ertain other lipids play an elementary role in the formation
f membrane domains. Results from initial studies investi-
ating in vitro activated lymphocytes or lymphocytes isolated
rom patients with autoimmune diseases show that the levels of
holesterol and GM1 (and possibly of other lipids) are increased
ompared to healthy cells. It is feasible that changes in lipid com-
osition modify membrane organization possibly by increasing
he abundance or the size of lipid raft domains. Alteration of the
lasma membrane may be linked to the changes in localization
nd function of signalling proteins seen in autoimmune lym-
hocytes, although modulation of other cellular functions such
s trafficking, internalization, membrane fusion and others will
lmost certainly occur, which in turn will have further impact on
ignalling. This in itself may not be sufficient to start an autoim-
une response; however, in conjunction with other predisposing
actors it could facilitate initiation of autoimmunity. If this is a
orrect assumption then it raises the possibility that lipid rafts
ay be targets for the development of pharmaceuticals to control
berrant immune responses. Statins are obvious candidates for
uch intervention and their efficacy in autoimmune diseases is
urrently under investigation [92,93]. On the other hand, sterol-
helating agents, such as the antibiotic nystatin which is used as
n anti-fungal treatment, may have the opposite effect by assist-
ng in the activation of lymphocytes [94,95], although detailed
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tudies on its mechanism of action on lymphocytes are lim-
ted. Nevertheless, the prospect of lipid raft research moving
loser to clinical application is an exciting new development in
he field, although remaining controversies and potential new
urdles should not be underestimated.
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